ResMed Inc. ($RMD) Target: $48 Confident Investor Rating: Fair

Company name ResMed Inc.
Stock ticker RMD
Live stock price [stckqut]RMD[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $51.22
Target stock price (averages with growth) $70.95
Target stock price (averages with no growth) $54.32
Target stock price (manual assumptions) $44.58

“ResMed Inc. (ResMed), is a holding company for the ResMed Group. The
Company, through its subsidiaries, is a developer, manufacturer and
distributor of medical equipment for treating, diagnosing, and managing
sleep-disordered breathing and other respiratory disorders. Sleep-disordered
breathing (SDB), includes obstructive sleep apnea (OSA), and other
respiratory disorders that occur during sleep. It has developed a number of
products for SDB and other respiratory disorders including airflow
generators, diagnostic products, mask systems, headgear and other
accessories. Its manufacturing operations are located in Australia,
Singapore, France and the United States. Major distribution and sales sites
are located in the United States, Germany, France, the United Kingdom,
Switzerland, Australia, Norway and Sweden. On October 1, 2009, it acquired
100% of Laboratoires Narval SA. Laboratoires Narval manufactures and
distributes a mandibular repositioning device (MRD). ”

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.